What does CUSIP Y95308105 represent in this 13F holders report?

CUSIP Y95308105 is the security identifier for WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value used to aggregate holder disclosures.

How many institutions held WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in Q1 2022?

77 institutional investors reported WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value for Q1 2022. Use the holders table for investor-level position and value details.

Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Ordinary Shares, no par value
Total 13F shares: 47,551,964
Total 13F value: $95,097,268
Share change: +403,371
Put/Call ratio: 0%
SEC-reported price per share: $2.00
Number of holders: 77
Value change: -$1,035,989
Number of buys: 26
Number of sells: 47
Shares outstanding: 188,679,245

Security key

Y95308105

Report period

Q1 2022

Institutions

Top holders

WVE full security history Ownership snapshot Full 13F holder table Wave Life Sciences Ltd. SEC filings Wave Life Sciences Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 4.1% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 4.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 4.1%

MAVERICK CAPITAL LTD 3%

Bellevue Group AG 2.4%

PRIMECAP MANAGEMENT CO/CA/ 2.4%

M28 Capital Management LP 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	4.1%	$24,414,000 7,775,207 shares	—	31 Dec 2021
MAVERICK CAPITAL LTD	13F Company 13F	3%	$17,563,000 5,593,389 shares	—	31 Dec 2021
Bellevue Group AG	13F Company 13F	2.4%	$14,453,000 4,602,858 shares	—	31 Dec 2021
PRIMECAP MANAGEMENT CO/CA/	13F Company 13F	2.4%	$14,427,000 4,594,575 shares	—	31 Dec 2021
M28 Capital Management LP	13F Company 13F	2%	$11,824,000 3,765,588 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	1.5%	$9,086,000 2,894,363 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

47,551,964

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %